Institutional Ownership Denali Therapeutics Inc. (DNLI)
This table provides information about the institutional ownership of Denali Therapeutics Inc. (DNLI). We have compiled data on the 244 institutions that hold shares in the stock, with a total of 134 Million shares, which have been reported (via 13F filing form) to have a value of $1.77 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,174,562
shares
|
$174 Million
0.01% of portfolio
|
Q2 2024
Added 7.99%
|
|
Baillie Gifford & CO
|
Aug 06, 2025 Q2 2025 |
11,955,323
shares
|
$158 Million
0.13% of portfolio
|
Q2 2025
Reduced 1.11%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
11,810,735
shares
|
$156 Million
0.0% of portfolio
|
Q2 2025
Added 0.09%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
6,582,295
shares
|
$87 Million
0.01% of portfolio
|
Q2 2025
Added 50.72%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 14, 2025 Q2 2025 |
6,262,277
shares
|
$82.8 Million
0.02% of portfolio
|
Q2 2025
Reduced 7.46%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
5,664,733
shares
|
$74.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 50.35%
|
|
Temasek Holdings (Private) LTD
Singapore, U0 |
Aug 14, 2025 Q2 2025 |
5,355,832
shares
|
$70.8 Million
0.37% of portfolio
|
Q3 2024
New holding
|
|
Capital Research Global Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
4,750,579
shares
|
$62.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.31%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,517,994
shares
|
$59.7 Million
0.0% of portfolio
|
Q2 2025
Added 1.28%
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
3,947,387
shares
|
$52.2 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
Crestline Management, LP
Fort Worth, TX |
Aug 14, 2025 Q2 2025 |
3,860,732
shares
|
$51 Million
86.33% of portfolio
|
Q2 2025
Reduced 7.21%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,731,695
shares
|
$49.3 Million
0.53% of portfolio
|
Q1 2024
Added 43.13%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
3,246,934
shares
|
$42.9 Million
0.03% of portfolio
|
Q2 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
3,172,305
shares
|
$41.9 Million
0.0% of portfolio
|
Q2 2025
Added 4.45%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
3,137,140
shares
|
$41.5 Million
0.02% of portfolio
|
Q2 2025
Reduced 0.55%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,412,928
shares
|
$31.9 Million
0.01% of portfolio
|
Q2 2025
Added 14.85%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
2,213,947
shares
|
$29.3 Million
0.07% of portfolio
|
Q2 2025
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,865,324
shares
|
$24.7 Million
0.0% of portfolio
|
Q2 2025
Added 11.56%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,566,246
shares
|
$20.7 Million
0.03% of portfolio
|
Q1 2024
Reduced 0.63%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Aug 13, 2025 Q2 2025 |
1,515,991
shares
|
$20 Million
0.01% of portfolio
|
Q2 2025
Added 11.06%
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
1,405,250
shares
|
$18.6 Million
0.02% of portfolio
|
Q2 2025
Reduced 35.79%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,312,016
shares
|
$17.3 Million
0.0% of portfolio
|
Q2 2025
Added 4.66%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,248,953
shares
|
$16.5 Million
0.0% of portfolio
|
Q2 2025
Added 6.78%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
1,201,709
shares
|
$15.9 Million
0.0% of portfolio
|
Q2 2025
Added 6.14%
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
1,072,983
shares
|
$14.2 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.79%
|